Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000880448 | SCV001023544 | likely benign | not provided | 2023-12-15 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002501377 | SCV002806337 | likely benign | Agammaglobulinemia 8, autosomal dominant; Agammaglobulinemia 8b, autosomal recessive | 2021-10-19 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002539292 | SCV003698342 | uncertain significance | Inborn genetic diseases | 2021-09-16 | criteria provided, single submitter | clinical testing | The c.1948C>A (p.P650T) alteration is located in exon 19 (coding exon 18) of the TCF3 gene. This alteration results from a C to A substitution at nucleotide position 1948, causing the proline (P) at amino acid position 650 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |